**Agomab Sets Price for Initial Public Offering of 12.5 Million ADSs**
Agomab has finalized the pricing for its initial public offering (IPO), offering 12,500,000 American Depositary Shares (ADSs). Each ADS corresponds to one common share of the company. The IPO marks a significant step for Agomab as it seeks to raise capital and expand its operations. Details regarding the offering price …